This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Repatha (evolocumab) 140 mg/mL SureClick autoinjector medication. The contract has a total ceiling value of $1,016.82 and a period of performance running through November 6, 2024.
The contract is an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a larger vehicle valued at $999,999,999 and valid through November 2026. This IDC serves as a primary mechanism for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, AmerisourceBergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
Generated 2/4/25, 10:31 AM